- call +1-201-465-4211
- email sales@mrinsights.biz
Drug delivery system introduces therapeutic substance in the body as formulation or device to improve its efficiency and safety. There was requirement drug delivery system that could maintain the steady release of therapeutic drugs within the specific site. Implantable drug delivery system becomes new kind of drug delivery system which can directly implant in the human body to optimize therapeutic properties. This system is more steady, effective, safe and reliable than other drug delivery system. For intravenous drug delivery system, drugs actions were short, and frequent injections were required. For topical drug delivery system, absorption drug may be limited due physiochemical characteristic of drugs. Implantable drug delivery system does not have limitation associated with intravenous and topical drug delivery system beside it is controlled drug delivery system.
Scope of the Report:
The worldwide market for Implantable Drug Delivery Systems is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Implantable Drug Delivery Systems in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Boston Scientific Corporation
Bayer Healthcare
Medtronic Inc.
Allergan Inc.
Abbott laboratories
Bausch and Lomb Inc.
Genetech Inc.
PSivda Corporation
Medtronic
Varian Medical System
Arrow International
Neurotech Pharmaceuticals
Replenish Inc.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Biodegradable
Non-Biodegradable
Market Segment by Applications, can be divided into
Diabetic retinopathy
Cardiovascular diseases
Colorectal cancer
Osteoporosis
Ocular diseases
Brain tumors
Other
There are 15 Chapters to deeply display the global Implantable Drug Delivery Systems market.
Chapter 1, to describe Implantable Drug Delivery Systems Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Implantable Drug Delivery Systems, with sales, revenue, and price of Implantable Drug Delivery Systems, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Implantable Drug Delivery Systems, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Implantable Drug Delivery Systems market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Implantable Drug Delivery Systems sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Implantable Drug Delivery Systems Introduction
1.2 Market Analysis by Type
1.2.1 Biodegradable
1.2.2 Non-Biodegradable
1.3 Market Analysis by Applications
1.3.1 Diabetic retinopathy
1.3.2 Cardiovascular diseases
1.3.3 Colorectal cancer
1.3.4 Osteoporosis
1.3.5 Ocular diseases
1.3.6 Brain tumors
1.3.7 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Boston Scientific Corporation
2.1.1 Business Overview
2.1.2 Implantable Drug Delivery Systems Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Boston Scientific Corporation Implantable Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bayer Healthcare
2.2.1 Business Overview
2.2.2 Implantable Drug Delivery Systems Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bayer Healthcare Implantable Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Medtronic Inc.
2.3.1 Business Overview
2.3.2 Implantable Drug Delivery Systems Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Medtronic Inc. Implantable Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Allergan Inc.
2.4.1 Business Overview
2.4.2 Implantable Drug Delivery Systems Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Allergan Inc. Implantable Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Abbott laboratories
2.5.1 Business Overview
2.5.2 Implantable Drug Delivery Systems Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Abbott laboratories Implantable Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bausch and Lomb Inc.
2.6.1 Business Overview
2.6.2 Implantable Drug Delivery Systems Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bausch and Lomb Inc. Implantable Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Genetech Inc.
2.7.1 Business Overview
2.7.2 Implantable Drug Delivery Systems Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Genetech Inc. Implantable Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 PSivda Corporation
2.8.1 Business Overview
2.8.2 Implantable Drug Delivery Systems Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 PSivda Corporation Implantable Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Medtronic
2.9.1 Business Overview
2.9.2 Implantable Drug Delivery Systems Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Medtronic Implantable Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Varian Medical System
2.10.1 Business Overview
2.10.2 Implantable Drug Delivery Systems Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Varian Medical System Implantable Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Arrow International
2.11.1 Business Overview
2.11.2 Implantable Drug Delivery Systems Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Arrow International Implantable Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Neurotech Pharmaceuticals
2.12.1 Business Overview
2.12.2 Implantable Drug Delivery Systems Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Neurotech Pharmaceuticals Implantable Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Replenish Inc.
2.13.1 Business Overview
2.13.2 Implantable Drug Delivery Systems Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Replenish Inc. Implantable Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Implantable Drug Delivery Systems Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Implantable Drug Delivery Systems Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Implantable Drug Delivery Systems Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Implantable Drug Delivery Systems Manufacturer Market Share in 2017
3.3.2 Top 6 Implantable Drug Delivery Systems Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Implantable Drug Delivery Systems Market Analysis by Regions
4.1 Global Implantable Drug Delivery Systems Sales, Revenue and Market Share by Regions
4.1.1 Global Implantable Drug Delivery Systems Sales and Market Share by Regions (2013-2018)
4.1.2 Global Implantable Drug Delivery Systems Revenue and Market Share by Regions (2013-2018)
4.2 North America Implantable Drug Delivery Systems Sales and Growth Rate (2013-2018)
4.3 Europe Implantable Drug Delivery Systems Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Implantable Drug Delivery Systems Sales and Growth Rate (2013-2018)
4.5 South America Implantable Drug Delivery Systems Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Implantable Drug Delivery Systems Sales and Growth Rate (2013-2018)
5 North America Implantable Drug Delivery Systems by Countries
5.1 North America Implantable Drug Delivery Systems Sales, Revenue and Market Share by Countries
5.1.1 North America Implantable Drug Delivery Systems Sales and Market Share by Countries (2013-2018)
5.1.2 North America Implantable Drug Delivery Systems Revenue and Market Share by Countries (2013-2018)
5.2 United States Implantable Drug Delivery Systems Sales and Growth Rate (2013-2018)
5.3 Canada Implantable Drug Delivery Systems Sales and Growth Rate (2013-2018)
5.4 Mexico Implantable Drug Delivery Systems Sales and Growth Rate (2013-2018)
6 Europe Implantable Drug Delivery Systems by Countries
6.1 Europe Implantable Drug Delivery Systems Sales, Revenue and Market Share by Countries
6.1.1 Europe Implantable Drug Delivery Systems Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Implantable Drug Delivery Systems Revenue and Market Share by Countries (2013-2018)
6.2 Germany Implantable Drug Delivery Systems Sales and Growth Rate (2013-2018)
6.3 UK Implantable Drug Delivery Systems Sales and Growth Rate (2013-2018)
6.4 France Implantable Drug Delivery Systems Sales and Growth Rate (2013-2018)
6.5 Russia Implantable Drug Delivery Systems Sales and Growth Rate (2013-2018)
6.6 Italy Implantable Drug Delivery Systems Sales and Growth Rate (2013-2018)
7 Asia-Pacific Implantable Drug Delivery Systems by Countries
7.1 Asia-Pacific Implantable Drug Delivery Systems Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Implantable Drug Delivery Systems Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Implantable Drug Delivery Systems Revenue and Market Share by Countries (2013-2018)
7.2 China Implantable Drug Delivery Systems Sales and Growth Rate (2013-2018)
7.3 Japan Implantable Drug Delivery Systems Sales and Growth Rate (2013-2018)
7.4 Korea Implantable Drug Delivery Systems Sales and Growth Rate (2013-2018)
7.5 India Implantable Drug Delivery Systems Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Implantable Drug Delivery Systems Sales and Growth Rate (2013-2018)
8 South America Implantable Drug Delivery Systems by Countries
8.1 South America Implantable Drug Delivery Systems Sales, Revenue and Market Share by Countries
8.1.1 South America Implantable Drug Delivery Systems Sales and Market Share by Countries (2013-2018)
8.1.2 South America Implantable Drug Delivery Systems Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Implantable Drug Delivery Systems Sales and Growth Rate (2013-2018)
8.3 Argentina Implantable Drug Delivery Systems Sales and Growth Rate (2013-2018)
8.4 Colombia Implantable Drug Delivery Systems Sales and Growth Rate (2013-2018)
9 Middle East and Africa Implantable Drug Delivery Systems by Countries
9.1 Middle East and Africa Implantable Drug Delivery Systems Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Implantable Drug Delivery Systems Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Implantable Drug Delivery Systems Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Implantable Drug Delivery Systems Sales and Growth Rate (2013-2018)
9.3 UAE Implantable Drug Delivery Systems Sales and Growth Rate (2013-2018)
9.4 Egypt Implantable Drug Delivery Systems Sales and Growth Rate (2013-2018)
9.5 Nigeria Implantable Drug Delivery Systems Sales and Growth Rate (2013-2018)
9.6 South Africa Implantable Drug Delivery Systems Sales and Growth Rate (2013-2018)
10 Global Implantable Drug Delivery Systems Market Segment by Type
10.1 Global Implantable Drug Delivery Systems Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Implantable Drug Delivery Systems Sales and Market Share by Type (2013-2018)
10.1.2 Global Implantable Drug Delivery Systems Revenue and Market Share by Type (2013-2018)
10.2 Biodegradable Sales Growth and Price
10.2.1 Global Biodegradable Sales Growth (2013-2018)
10.2.2 Global Biodegradable Price (2013-2018)
10.3 Non-Biodegradable Sales Growth and Price
10.3.1 Global Non-Biodegradable Sales Growth (2013-2018)
10.3.2 Global Non-Biodegradable Price (2013-2018)
11 Global Implantable Drug Delivery Systems Market Segment by Application
11.1 Global Implantable Drug Delivery Systems Sales Market Share by Application (2013-2018)
11.2 Diabetic retinopathy Sales Growth (2013-2018)
11.3 Cardiovascular diseases Sales Growth (2013-2018)
11.4 Colorectal cancer Sales Growth (2013-2018)
11.5 Osteoporosis Sales Growth (2013-2018)
11.6 Ocular diseases Sales Growth (2013-2018)
11.7 Brain tumors Sales Growth (2013-2018)
11.8 Other Sales Growth (2013-2018)
12 Implantable Drug Delivery Systems Market Forecast (2018-2023)
12.1 Global Implantable Drug Delivery Systems Sales, Revenue and Growth Rate (2018-2023)
12.2 Implantable Drug Delivery Systems Market Forecast by Regions (2018-2023)
12.2.1 North America Implantable Drug Delivery Systems Market Forecast (2018-2023)
12.2.2 Europe Implantable Drug Delivery Systems Market Forecast (2018-2023)
12.2.3 Asia-Pacific Implantable Drug Delivery Systems Market Forecast (2018-2023)
12.2.4 South America Implantable Drug Delivery Systems Market Forecast (2018-2023)
12.2.5 Middle East and Africa Implantable Drug Delivery Systems Market Forecast (2018-2023)
12.3 Implantable Drug Delivery Systems Market Forecast by Type (2018-2023)
12.3.1 Global Implantable Drug Delivery Systems Sales Forecast by Type (2018-2023)
12.3.2 Global Implantable Drug Delivery Systems Market Share Forecast by Type (2018-2023)
12.4 Implantable Drug Delivery Systems Market Forecast by Application (2018-2023)
12.4.1 Global Implantable Drug Delivery Systems Sales Forecast by Application (2018-2023)
12.4.2 Global Implantable Drug Delivery Systems Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Implantable Drug Delivery Systems Picture
Table Product Specifications of Implantable Drug Delivery Systems
Figure Global Sales Market Share of Implantable Drug Deli
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
